<DOC>
	<DOCNO>NCT00230659</DOCNO>
	<brief_summary>The inherited disease hereditary haemorrhagic telangiectasia ( HHT ) cause bleed dilate fragile vessel , particularly nose gut . However , many HHT patient develop deep venous thromboses and/or pulmonary embolism , necessitate treatment anticoagulant impair control haemorrhagic state . Our initial observation use general coagulation test suggest blood HHT patient intrinsically hypercoagulable . We hypothesize genetically-determined abnormality blood vessel HHT patient lead alteration concentration activity one several protein affect blood clot lead hypercoagulable state . We propose study level activity blood coagulation factor people hereditary haemorrhagic telangiectasia normal volunteer . This define significance basis initial observation , significant implication clinical management HHT patient .</brief_summary>
	<brief_title>Investigation Coagulation Parameters Hereditary Haemorrhagic Telangiectasia</brief_title>
	<detailed_description />
	<mesh_term>Telangiectasis</mesh_term>
	<mesh_term>Telangiectasia , Hereditary Hemorrhagic</mesh_term>
	<criteria>Patients HHT normal control Previous thrombosis , recent ill health</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
</DOC>